Tweetovi

Blokirali ste korisnika/cu @WhiteResearch

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @WhiteResearch

  1. 3. velj

    We've published a new bearish report on NanoViricides . We've got some comical goodies in there, and it got Editor's Pick by Seeking Alpha.

    Poništi
  2. 29. sij

    We've published a new bearish report on Alphatec . We believe it will have problems similar to those of .

    Poništi
  3. 22. sij

    We've published an update on Accelerate Diagnostics . Our analysis proved to be dead-on accurate.

    Poništi
  4. 15. sij

    Good observation on . $1B market cap is insane for this company that hospitals don't like to use its diagnostic machines, a new CEO won't change that. It was a failed launch from the start.

    Poništi
  5. 6. sij

    We tried to warn shareholders regarding . But if anyone lost over $50K, you might be able to recover some:

    Poništi
  6. 3. sij

    Update on . Company is almost out of cash, still in the mice study stage. Longs are in trouble, I'm not sure what they are hoping for.

    Poništi
  7. 31. pro 2019.

    Helius Medical update report. This is a slam dunk short. Helius' own study again shows that their device doesn't work.

    Poništi
  8. 23. pro 2019.
    Poništi
  9. 12. pro 2019.

    New WaPo article. A convicted sex offender was one of 's most popular live streamers. When MeetMe found out he was a sex offender, they let him keep streaming.

    Poništi
  10. 11. pro 2019.

    We've published a bearish report on , explaining why their new hyped-up vPaaS (Video Platform As A Service) product won't generate material revenue.

    Poništi
  11. 5. pro 2019.

    's lead scientist, Gumrukcu, is practicing medicine in California without a license, and is doing leech treatments, yes leech treatments at the Seraph Institute.

    Poništi
  12. 5. pro 2019.

    We've reported on new, bizarre developments in Enochian Biosciences . This is the most overvalued preclinical biotech we've ever seen, which we believe is part of the rig.

    Poništi
  13. 3. pro 2019.

    is rekt. Murata made a bad investment.

    Poništi
  14. 27. stu 2019.
    Poništi
  15. 25. stu 2019.

    HBV drug licensed from Serhat, there’s still no HIV data, Serhat still has no official degrees. There’s still no prince agreement - makes no sense. See our report here for details:

    Poništi
  16. 25. stu 2019.

    PR doesn't mean anything. No data on their HIV pipeline. They introduce another preclinical drug for HBV treatment, not making any progress past preclinical stage. Doesn't say where Serhat earned his MD or PHD, which are still questionable.

    Poništi
  17. proslijedio/la je Tweet
    24. stu 2019.

    This week was wild. Learn about the carnage and rebound at Kasen, developments in , take on and lastly the insane story behind , courtesy of

    Poništi
  18. 22. stu 2019.

    has voiced only one dispute with our article. In the interest of full disclosure, read the dispute and our response on our website here:

    Poništi
  19. 21. stu 2019.

    A shareholder lawsuit just started on for those who lost money and were ignorant of the facts:

    Poništi
  20. 19. stu 2019.
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·